Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study to test warning system and proteomics to detect early breast cancer begun
September 8th, 2005
Lifeline Biotechnologies, Inc. (LBTN) announced that Professor Kefah Mokbel, consultant breast surgeon at St. George's Hospital and Medical School and professor at Brunel Institute of Cancer Genetics & Pharmacogenomics and his research team in the U.K. have commenced a new study. Researchers in the study are examining the role of mammary ductoscopy, using MastaScope, in conjunction with dynamic thermal analysis, using the First Warning System and proteomics in the early detection of breast cancer. This study has been approved by the Ethics' Committee at St. George's Hospital Medical School in London. Participants include patients...
Source: Women's Health Weekly (2005-09-08)
|
